| Product Code: ETC7184467 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Psychedelic Drugs Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Psychedelic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Psychedelic Drugs Market - Industry Life Cycle |
3.4 Fiji Psychedelic Drugs Market - Porter's Five Forces |
3.5 Fiji Psychedelic Drugs Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 Fiji Psychedelic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Fiji Psychedelic Drugs Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Fiji Psychedelic Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Fiji Psychedelic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Fiji Psychedelic Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Fiji Psychedelic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance and recognition of the therapeutic benefits of psychedelic drugs in treating mental health disorders. |
4.2.2 Growing research and development activities focused on exploring the potential of psychedelic drugs. |
4.2.3 Rising prevalence of mental health issues and the need for alternative treatment options. |
4.3 Market Restraints |
4.3.1 Regulatory challenges and legal restrictions surrounding the use and distribution of psychedelic drugs. |
4.3.2 Lack of standardized dosing guidelines and treatment protocols for psychedelic therapies. |
4.3.3 Stigma and societal perception associated with psychedelic drugs hindering widespread adoption. |
5 Fiji Psychedelic Drugs Market Trends |
6 Fiji Psychedelic Drugs Market, By Types |
6.1 Fiji Psychedelic Drugs Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Fiji Psychedelic Drugs Market Revenues & Volume, By Source, 2021- 2031F |
6.1.3 Fiji Psychedelic Drugs Market Revenues & Volume, By Synthetic, 2021- 2031F |
6.1.4 Fiji Psychedelic Drugs Market Revenues & Volume, By Natural, 2021- 2031F |
6.2 Fiji Psychedelic Drugs Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Fiji Psychedelic Drugs Market Revenues & Volume, By Empathogens, 2021- 2031F |
6.2.3 Fiji Psychedelic Drugs Market Revenues & Volume, By Dissociatives, 2021- 2031F |
6.3 Fiji Psychedelic Drugs Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Fiji Psychedelic Drugs Market Revenues & Volume, By Gamma-Hydroxybutyric Acid, 2021- 2031F |
6.3.3 Fiji Psychedelic Drugs Market Revenues & Volume, By Ketamine, 2021- 2031F |
6.3.4 Fiji Psychedelic Drugs Market Revenues & Volume, By Psilocybin, 2021- 2031F |
6.4 Fiji Psychedelic Drugs Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Fiji Psychedelic Drugs Market Revenues & Volume, By Treatment Resistant Depression, 2021- 2031F |
6.4.3 Fiji Psychedelic Drugs Market Revenues & Volume, By Major Depressive Disorder, 2021- 2031F |
6.4.4 Fiji Psychedelic Drugs Market Revenues & Volume, By Opiate Addiction, 2021- 2031F |
6.4.5 Fiji Psychedelic Drugs Market Revenues & Volume, By Post-Traumatic Stress Disorder, 2021- 2031F |
6.5 Fiji Psychedelic Drugs Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Fiji Psychedelic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Fiji Psychedelic Drugs Market Revenues & Volume, By Inhalation, 2021- 2031F |
6.5.4 Fiji Psychedelic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.6 Fiji Psychedelic Drugs Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Fiji Psychedelic Drugs Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6.3 Fiji Psychedelic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Fiji Psychedelic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
7 Fiji Psychedelic Drugs Market Import-Export Trade Statistics |
7.1 Fiji Psychedelic Drugs Market Export to Major Countries |
7.2 Fiji Psychedelic Drugs Market Imports from Major Countries |
8 Fiji Psychedelic Drugs Market Key Performance Indicators |
8.1 Number of clinical trials conducted on psychedelic drugs in Fiji. |
8.2 Investment inflow into the psychedelic drugs market in Fiji. |
8.3 Number of healthcare professionals trained in administering psychedelic-assisted therapies in Fiji. |
8.4 Public perception surveys on the acceptance and understanding of psychedelic drugs for therapeutic purposes in Fiji. |
8.5 Number of government policies or regulations supporting the use of psychedelic drugs for mental health treatment in Fiji. |
9 Fiji Psychedelic Drugs Market - Opportunity Assessment |
9.1 Fiji Psychedelic Drugs Market Opportunity Assessment, By Source, 2021 & 2031F |
9.2 Fiji Psychedelic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Fiji Psychedelic Drugs Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Fiji Psychedelic Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Fiji Psychedelic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Fiji Psychedelic Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Fiji Psychedelic Drugs Market - Competitive Landscape |
10.1 Fiji Psychedelic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Fiji Psychedelic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here